News
FDA Approves Bemotrizinol: First New Sunscreen Ingredient in 25 Years to Hit U.S. Market in 2026
The FDA approved bemotrizinol on June 9, 2026 — the first new sunscreen ingredient in the U.S. in more than 25 years. It provides superior UVA protection already used worldwide.
→
Post-Transplant Alcohol Relapse Falls to Zero Under Mayo Clinic Protocol
Mayo Clinic's PACT protocol achieved 0% heavy alcohol relapse in post-liver transplant patients within one year — vs. a historical rate of ~25%. Published June 3, 2026 in Liver Transplantation journal.
→
Medicare Is About to Cover Weight-Loss Drugs for the First Time — Here's What the GLP-1 Bridge Program Means for Millions of Americans with Obesity
Medicare's GLP-1 Bridge launches July 1, 2026, offering eligible Part D enrollees Wegovy and Zepbound for $50/month — the first-ever Medicare coverage for obesity-specific GLP-1 drugs.
→
